FDA Approves Allergan’s New Juvederm Formulation
The company claims that Juvederm is the first and only hyaluronic acid dermal filler approved by the FDA to last up to one year from initial treatment. Juvederm
The US Food and Drug Administration (FDA) is set to review Kowa Pharmaceuticals America’s new drug application (NDA) for K-911, an investigational once-daily eye drop aimed at reducing intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) patients.